the Quarter ended March 31, 2018 To : Director and Manager Stock Exchange of Thailand Abico Holdings Public Company Limited would like explanation about the Company’s financial performance and operation

and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the audited separated and consolidated financial statements for the year ended

Registration No. : 0107535000371 No. L001/2019 20th February 2019 Subject : The explanation of operating results for the year 2018 Attention : The President The Stock Exchange of Thailand Dear Sir, For the year

Microsoft Word - MD&A Y2018-E.doc 1 Ref: CSO. 003/2019 Date: 20th February 2019 Subject: Management Discussion and Analysis for Year Ending 31st December 2018 Attention: President The Stock Exchange

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

Microsoft Word - MD&A Y2019-E FA.doc 1 Ref: CSO. 003/2020 Date: 19th February 2020 Subject: Management Discussion and Analysis for Year Ending 31st December 2019 Attention: President The Stock

-TRANSLATION- 25 February 2020 Subject : Management Discussion and Analysis for 2019 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in

the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company

ABICO 009/KV/2017 May 11, 2017 Subject : Explanation on operation result for the Quarter ended March 31, 2017 To : Director and Manager Stock Exchange of Thailand Abico Holdings Public Company

-TRANSLATION- 11 August 2017 Subject : Management Discussion and Analysis for Q2/2017 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in